Inhibitory effects of rosa roxburghii tratt juice on in vitro oxidative modification of low density lipoprotein and on the macrophage growth and cellular cholesteryl ester accumulation induced by oxidized low density lipoprotein

Clinica Chimica Acta

Volumn 313, Issue 1-2, 2001, Pages 37-43

  Zhang, Chunni ^a   Liu, Xiaozhuan ^a   Qiang, Hongjuan ^a   Li, Ke ^a   Wang, Junjun ^a   Chen, Daning ^a   Zhuang, Yiyi ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Atherosclerosis; Foam cell; Oxidative modification; Oxidized LDL; Rosa roxburghii tratt juice

Indexed keywords

ALKADIENE; CHOLESTEROL ESTER; HERBACEOUS AGENT; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; ROSA ROXBURGHII TRATT EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ASSAY; ATHEROSCLEROSIS; CELL COUNT; CELL GROWTH; CELL LEVEL; CHOLESTEROL METABOLISM; CONFERENCE PAPER; CONJUGATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTROPHORETIC MOBILITY; FOAM CELL; GROWTH INHIBITION; IN VITRO STUDY; INHIBITION KINETICS; MALE; MOUSE; NONHUMAN; OXIDATION; PERITONEUM MACROPHAGE; PLANT; PRIORITY JOURNAL; ROSA ROXBURGHII TRATT;

ANIMALS; CHOLESTEROL ESTERS; LIPOPROTEINS, LDL; MACROPHAGES, PERITONEAL; MICE; OXIDATION-REDUCTION; PLANT EXTRACTS; ROSA; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0034748638     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00647-7     Document Type: Conference Paper

References (37)

1. Modifications of low density lipoprotein that increase its atherogenicity
2. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
3. Autoantibody against oxidised LDL and progression of carotid atherosclerosis
4. LDL oxidation in patients with severe carotid atherosclerosis - A study of in vitro and in vivo oxidation markers
5. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease
6. Beyond cholesterol modification of low-density lipoprotein that increases its atherogenicity
7. Lysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derived macrophages
8. Antiatherogenic effect of probucol to its hypocholesterolemic effect evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit
9. Vitamin E consumption and the risk of coronary heart disease in men
10. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N′-diphenylphenylenediamine
11. Chronic toxicity of butylated hydroxytoluene in Wistar rats
12. Anti-atherosclerosis effect of rose roxburghii tratt
13. Advances in study of rosa roxburghii tratt
14. Effect of rosa roxburghii tratt juice enhanced by SOD on lipid peroxidation of coronary heart disease cases
15. Effects of rosa roxburghii tratt on experimental hyperlipidemia and atherosclerosis in quails
16. Effects of rosa roxburghii juice on the experimental hyperlipidemia and arteriosclerosis in rabbits
17. Expression of superoxide dismutase following axotomy
18. Study of trace elements from "CICI" and "CICI"'s polysaccharide
19. Distinction in the mode of receptor-mediated endocytosis between high density lipoprotein and acetylated high density lipoprotein: Evidence for high density lipoprotein receptor-mediated cholesterol transfer
20. 2+-catalyzed oxidation of human low density lipoprotein
21. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid
22. Continuous monitoring of in vitro oxidation of human low density lipoprotein
23. Induction of murine macrophage growth by modified LDLs
24. The very low- and intermediate-density lipoprotein fraction isolated from apolipoprotein E-knockout mice transforms macrophages to foam cells through an apolipoprotein E-independent pathway
25. Species difference in cholesteryl ester cycle and HDL-induced cholesterol efflux from macrophage foam cells
26. Tannins and related polyphenols of rosaceous medicinal plants: IV. Roxbina A and B from rosa roxburghii fruits
27. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage
28. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification
29. The reversibility of atherosclerosis
30. Glycosylation enhances oxygen radical-induced modifications and decreases acetylhydrolase activity of human low density lipoprotein
31. Overexpression of human superoxide dismutase inhibits oxidation of low-density lipoprotein by endothelial cells
32. Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: In vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice
33. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression in atherosclerosis in the Watanabe heritable hyperlipidemic rabbit
34. The antioxidant butylated hydroxytoluene protects against atherosclerosis
35. Inhibition of phIP mutagenicity by caffeine, lycopene, daidzein, and genistein